PEA3 activates VEGF transcription in T47D and SKBR3 breast cancer cells

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 1, 2009, Pages 63-68

  Hua, Dong ^a   Chen, Bobin ^b   Bai, Mei ^a   Yu, Hao ^a   Wu, Xiaohong ^a   Jin, Wei ^a,c  

^a Soochow University   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

PEA3; Transcription regulation; VEGF promoter

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PEA3; VASCULOTROPIN A;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; PHYSIOLOGY; PROMOTER REGION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; HUMANS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64049096408     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmn007     Document Type: Article

References (26)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1: 27-31.
2. Battegay EJ. Angiogenesis, mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med, 1995, 73: 333-346.
3. Gao X and Xu Z. Mechanisms of action of angiogenin. Acta Biochim Biophys Sin 2008, 40: 619-624.
4. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999, 77: 527-543.
5. Neufeld G, Cohen T, Gengrinovitch S and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999, 13: 9-22.
6. Kim KJ, Li B, Houck K, Winer J and Ferrara N. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 1992, 7: 53-64.
7. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS and Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362: 841-844.
8. Stoner M, Wang F, Wormke M, Nguyen T, Samudio I, Vyhlidal C and Marme D, et al. Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins. J Biol Chem 2000, 275: 22769-22779.
9. Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M and Safe S. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Oncogene 2004, 23: 1052-1063.
10. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996, 16: 4604-4613.
11. Kawai H, Li H, Chun P, Avraham S and Avraham HK. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene 2002, 21: 7730-7739.
12. Cowden Dahl KD, Zeineldin R and Hudson LG. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells. Mol Cancer Res 2007, 5: 413-421.
13. Xin JH, Cowie A, Lachance P and Hassel JA. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev 1992, 6: 481-496.
14. Monte D, Coutte L, Baert JL, Angeli I, Stehelin D and de Launoit Y. Molecular characterization of the Ets-related human transcription factor ER81. Oncogene 1995, 11: 771-779.
15. Monte D, Baert JL, Defossez PA, de Launoit Y and Stehelin D. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors. Oncogene 1994, 9: 1397-1406.
16. Scott GK, Daniel JC, Xiong X, Maki RA, Kabat D and Benz CC. Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells. J Biol Chem 1994, 269: 19848-19858.
17. Benz CC, O'Hagan RC, Richter B, Scott GK, Chang C-H, Xiong X and Chew K, et al. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 1997, 15:1513-1525.
18. Hiroumi H, Dosaka-Akita H, Yoshida K, Shindoh M, Ohbuchi T, Fujinaga K and Nishimura M. Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion. Int J Cancer 2001, 93: 786-791.
19. Hida K, Shindoh M, Yasuda M, Hanzawa M, Funaoka K, Kohgo T and Amemiya A, et al. Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities. Am J Pathol 1997, 150: 2125-2132.
20. Hida K, Shindoh M, Yoshida K, Kudoh A, Furaoka K, Kohgo T and Fujinaga K, et al. Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinoma. Oral Oncol 1997, 33: 426-430.
21. Matrisian LM. Matrix metalloproteinase gene expression. Ann N Y Acad Sci 1994, 732: 42-50.
22. Higashino F, Yoshida K, Noumi T, Seiki M and Fujinaga K. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 1995, 10: 1461-1463.
23. Kaya M, Yoshida K, Higashino F, Mitaka T, Ishii S and Fujinaga K. A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene 1996, 12: 221-227.
24. Shepherd TG, Kockeritz L, Szrajber MR, Muller WJ and Hassell JA. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis. Curr Biol 2001, 11: 1739-1748.
25. Su Z, Shi Y, Friedman R, Qiao L, McKinstry R, Hinman D and Dent P, et al. PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells. Nucleic Acids Res 2001, 29: 1661-1671.
26. Su ZZ, Shi YJ and Fisher PB. Cooperation between AP1 and PEA3 sites within the progression elevated gene-3 (PEG-3) promoter regulate basal and differential expression of PEG-3 during progression of the oncogenic phenotype in transformed rat embryo cells. Oncogene 2000, 19: 3411-3421.